# FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

> **NCT04016389** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 31 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel
- **PROCEDURE:** Trachelectomy

## Key facts

- **NCT ID:** NCT04016389
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-02-11
- **Primary completion:** 2026-12
- **Final completion:** 2028-12
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2025-08-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04016389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04016389, "FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04016389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*